| CXSL1800126 | 注射用A型肉毒神经毒素(150KD) | botulinum toxin type A | Lyophilized | Biological Products(7) | New Drug Application | 2018-12-27 | 兰州生物技术开发有限公司 | Lanzhou Biotechnique Development Co Ltd | In Review | 2018-12-26 | view |
| JXSS2100001 | 注射用A型肉毒毒素（150KD,不含复合蛋白） | botulinum toxin type A | Lyophilized | Biological Products(3.1) | Import Drug Application | 2021-01-08 | 麦施商务管理咨询（上海）有限公司 | Maishi Business Management Consulting (Shanghai) Co Ltd | In Review | 2021-01-07 | view |
| JXSS2100002 | 注射用A型肉毒毒素（150KD,不含复合蛋白） | botulinum toxin type A | Lyophilized | Biological Products(3.1) | Import Drug Application | 2021-01-08 | 麦施商务管理咨询（上海）有限公司 | Maishi Business Management Consulting (Shanghai) Co Ltd | In Review | 2021-01-07 | view |
| CXSL2300214 | 注射用A型肉毒毒素（148 kDa，不含复合蛋白） | botulinum toxin type A | Lyophilized | Biological Products(3.2) | New Drug Application | 2023-03-24 | | Lanzhou Biotechnique Development Co Ltd | | | view |
| JTH1800262 | 注射用A型肉毒毒素工作效价标准品 | botulinum toxin type A | Other | Chemical Drugs | Disposable Import Drug Application | 2018-07-27 | Allergan Pharmaceuticals Ireland | Allergan Pharmaceuticals Ireland | Certificate Issued | 2018-08-13 | view |
| JXSL1400025 | 注射用A型肉毒毒素(150 KD,不含复合蛋白) | botulinum toxin type A | Lyophilized | Biological Products | Import Drug Application | 2014-04-17 | 精鼎医药研究开发（上海）有限公司 | Parexel China Co Ltd | Certificate Issued | 2016-08-09 | view |
| JXSL1400026 | 注射用A型肉毒毒素(150 KD,不含复合蛋白) | botulinum toxin type A | Lyophilized | Biological Products | Import Drug Application | 2014-04-03 | 精鼎医药研究开发（上海）有限公司 | Parexel China Co Ltd | Certificate Issued | 2016-08-09 | view |
| JYSB2100085 | 注射用A型肉毒毒素 | botulinum toxin type A | Lyophilized | Biological Products | Supplementary Application | 2021-03-31 | 博福－益普生（天津）制药有限公司 | Beaufour-Ipsen (Tianjin) Pharmaceutical Co Ltd | In Review | 2021-03-30 | view |
| JYSB2000448 | 注射用A型肉毒毒素 | botulinum toxin type A | Lyophilized | Biological Products | Supplementary Application | 2020-09-09 | 艾尔建信息咨询（上海）有限公司 | Allergan Consulting (Shanghai) Co Ltd | Filed | 2020-09-18 | view |
| JXSS2300053 | 注射用A型肉毒毒素 | botulinum toxin type A | Lyophilized | Biological Products(2.2) | Import Drug Application | 2023-07-06 | | | | | view |
| JXSS1800017 | 注射用A型肉毒毒素 | botulinum toxin type A | Lyophilized | Biological Products | Import Drug Application | 2018-09-03 | | | Certificate Issued | 2020-06-22 | view |
| CXSL2200601 | 注射用A型肉毒毒素 | botulinum toxin type A | Lyophilized | Biological Products(2.2) | New Drug Application | 2022-12-13 | | Lanzhou Biotechnique Development Co Ltd | | | view |
| JXSL1300065 | 注射用A型肉毒毒素 | botulinum toxin type A | Lyophilized | Biological Products | Import Drug Application | 2013-10-24 | 北京四环制药有限公司 | Beijing Sihuan Pharmaceutical Co Ltd | Certificate Issued | 2016-05-24 | view |
| JYSB1000021 | 注射用A型肉毒毒素 | botulinum toxin type A | Lyophilized | Biological Products | Supplementary Application | 2010-01-27 | Allergan Pharmaceuticals Ireland | Allergan Pharmaceuticals Ireland | Certificate Issued | 2012-03-27 | view |
| CXSL2000359 | 注射用A型肉毒毒素 | botulinum toxin type A | Lyophilized | Biological Products(3.4) | New Drug Application | 2020-12-16 | 兰州生物技术开发有限公司 | Lanzhou Biotechnique Development Co Ltd | In Review | 2020-12-15 | view |
| JYSB2400142 | 注射用A型肉毒毒素 | botulinum toxin type A | Lyophilized | Biological Products | Supplementary Application | 2024-07-02 | | | | | view |
| JXSS1900036 | 注射用A型肉毒毒素 | botulinum toxin type A | Lyophilized | Biological Products | Import Drug Application | 2019-06-27 | | Hugel Inc | Certificate Issued | 2020-10-26 | view |
| CXSL2300037 | 注射用A型肉毒毒素 | botulinum toxin type A | Lyophilized | Biological Products(3.2) | New Drug Application | 2023-01-13 | | Lanzhou Biotechnique Development Co Ltd | | | view |
| JYSB1600022 | 注射用A型肉毒毒素 | botulinum toxin type A | Lyophilized | Biological Products | Supplementary Application | 2016-02-25 | 艾尔建信息咨询（上海）有限公司 | Allergan Consulting (Shanghai) Co Ltd | Certificate Issued | 2017-08-29 | view |
| JYSB1200193 | 注射用A型肉毒毒素 | botulinum toxin type A | Lyophilized | Biological Products | Supplementary Application | 2012-07-25 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd | Certificate Issued | 2015-03-03 | view |
